InsiderTrades.com logo
Elon to Transform U.S. Economy?
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.

CALC Insider Trading

Insider Ownership Percentage: 53.30%
Insider Buying (Last 12 Months): $3,471,170.98
Insider Selling (Last 12 Months): $0.00

CalciMedica Insider Trading History Chart

This chart shows the insider buying and selling history at CalciMedica by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CalciMedica Share Price & Price History

Current Price: $5.74
Price Change: ▼ Price Decrease of -0.26 (-4.33%)
As of 05/3/2024 01:00 AM ET

This chart shows the closing price history over time for CALC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Gold Mania
From Stansberry Research   |   Ad
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
See his free reveal right here.

CalciMedica Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Eric W RobertsInsiderBuy746$3.90$2,909.4036,640View SEC Filing Icon  
1/23/2024Fred A MiddletonDirectorBuy679,384$3.70$2,513,720.80946,744View SEC Filing Icon  
1/23/2024Sanderling Venture Partners ViMajor ShareholderBuy243,356$3.70$900,417.20946,744View SEC Filing Icon  
12/11/2023Robert N WilsonDirectorBuy506$3.30$1,669.80182,161View SEC Filing Icon  
11/6/2023A. Rachel LehenyCEOBuy2,440$3.12$7,612.8016,840View SEC Filing Icon  
11/6/2023Eric W RobertsInsiderBuy2,400$3.12$7,488.0035,894View SEC Filing Icon  
11/3/2023A. Rachel LehenyCEOBuy5,000$2.85$14,250.0014,400View SEC Filing Icon  
11/3/2023Eric W RobertsInsiderBuy3,200$2.80$8,960.0016,587View SEC Filing Icon  
8/25/2023Eric W RobertsInsiderBuy736$3.18$2,340.485,000View SEC Filing Icon  
8/21/2023Eric W RobertsInsiderBuy1,750$3.25$5,687.503,550View SEC Filing Icon  
6/26/2023Eric W RobertsInsiderBuy1,200$3.70$4,440.0013,387View SEC Filing Icon  
6/23/2023Eric W RobertsInsiderBuy500$3.35$1,675.0016,185View SEC Filing Icon  
See Full Table
Dems have chosen Biden replacement?
From Paradigm Press   |   Ad
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.
See who it is HERE.

SEC Filings (Institutional Ownership Changes) for CalciMedica (NASDAQ:CALC)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CALC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CalciMedica Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024BML Capital Management LLC160,424$0.67M0.4%+10.3%1.494%Search for SEC Filing on Google Icon
2/2/2024Meritage Portfolio Management46,000$0.13M0.0%+360.0%0.810%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC145,424$0.42M0.3%+63.8%2.560%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP166,857$0.43M0.0%N/A2.938%Search for SEC Filing on Google Icon
7/31/2023Meritage Portfolio Management10,000$40K0.0%N/A0.177%Search for SEC Filing on Google Icon
7/24/2023BML Capital Management LLC88,781$0.36M0.3%N/A1.568%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CalciMedica logo
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
Read More on CalciMedica

Today's Range

Now: $5.74
Low: $5.74
High: $5.99

50 Day Range

MA: $4.44
Low: $3.39
High: $6.00

52 Week Range

Now: $5.74
Low: $1.75
High: $8.59

Volume

6,694 shs

Average Volume

21,063 shs

Market Capitalization

$61.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Who are the company insiders with the largest holdings of CalciMedica?

CalciMedica's top insider investors include:
  1. Fred A Middleton (Director)
  2. Sanderling Venture Partners Vi (Major Shareholder)
  3. Robert N Wilson (Director)
  4. Eric W Roberts (Insider)
  5. A Rachel Leheny (CEO)
Learn More about top insider investors at CalciMedica.

Who are the major institutional investors of CalciMedica?

CalciMedica's top institutional investors include:
  1. BML Capital Management LLC — 1.49%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of CalciMedica stock.

Which institutional investors are buying CalciMedica stock?

In the last quarter, CALC stock was purchased by institutional investors including:
  1. BML Capital Management LLC
Within the last year, these company insiders have bought CalciMedica stock:
  1. Fred A Middleton (Director)
  2. Sanderling Venture Partners Vi (Major Shareholder)
  3. Robert N Wilson (Director)
  4. Eric W Roberts (Insider)
  5. A Rachel Leheny (CEO)
Learn More investors buying CalciMedica stock.
Elon to Transform U.S. Economy?
From Porter & Company   |   Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.